Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma
Emily C. Matchett(Saint Louis University), Jacki Kornbluth(VA St. Louis Health Care System)
Cited by 14
Related Papers
Impaired NK Cytolytic Activity and Enhanced Tumor Growth in NK Lytic-Associated Molecule-Deficient Mice
|The Journal of Immunology|2009|26
Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth
|Biochemical Journal|2022|14